Development and evaluation of Panax notoginseng saponins contained in an in situ pH-triggered gelling system for sustained ocular posterior segment drug delivery
Peng Lu, Renxing Wang, Yue Xing, Yanquan Gao, Qingqing Zhang, Bin Xing, Ying Zhang, Changxiang Yu, Xinfu Cai, Qiang Shang, Dereje Kebebe, Jiaxin Pi, Zhidong Liu
Development and evaluation of Panax notoginseng saponins contained in an in situ pH-triggered gelling system for sustained ocular posterior segment drug delivery
Objective: This study aimed to lay the foundation for the research on Panax notoginseng saponins (PNS) in pH-sensitive in situ gel and the development and improvement of related preparations.Methods: We used Carbopol®940, a commonly used pH-sensitive polymer, and the thickener hydroxypropyl methylcellulose (HPMC E4M) as an ophthalmic gel matrix to prepare an ophthalmic in situ gel of PNS. In addition, formula optimization was performed by assessing gelling capability with the results of in vitro release studies. In vitro (corneal permeation, rheological, and stability) and in vivo (ocular irritation and preliminary pharmacokinetics in the vitreous) studies were also performed. Results: The results demonstrated that the in situ gelling systems containing PNS showed a sustained release of the drug, making it an ideal ocular delivery system for improving posterior ocular bioavailability. Conclusions: This study lays the foundation for the research of PNS contained in an in situ pH-triggered gel as well as the development and improvement of related preparations. It concurrently traditional Chinese medicine with a contemporary in situ gelling approach to provide new directions for the treatment of posterior ocular diseases such as diabetic retinopathy.
Carbopol®940 / Hydroxypropyl methylcellulose / Panax notoginseng saponins / pH-triggered gelling system / Sustained release drug delivery
[[1]] |
Chen Z, Li C, Yang C, et al. Lipid regulation effects of raw and processed Notoginseng Radix Et Rhizome on steatotic Hepatocyte L02 Cell. Biomed Res Int 2016;8(11):1-9.
|
[[2]] |
Fan Y, Qiao Y, Huang J, et al. Protective effects of Panax notoginseng saponins against high glucose-induced oxidative injury in rat retinal capillary endothelial cells. Evid Based Complement Alternat Med 2016;2:1-9.
|
[[3]] |
Jin Z, Gao L, Zhang L, et al. Antimicrobial activity of saponins produced by two novel endophytic fungi from Panax notoginseng. Nat Prod Res 2017;31(22):2700-2703.
|
[[4]] |
Liao J, Wei B, Chen H, et al. Bioinformatics investigation of therapeutic mechanisms of Xuesaitong capsule treating ischemic cerebrovascular rat model with comparative transcriptome analysis. Am J Transl Res 2016;8(5):2438-2449.
|
[[5]] |
Ratno Budiarto B, Chan WH. Oxidative stresses-mediated apoptotic effects of ginsenoside Rb1 on pre- and post-implantation mouse embryos in vitro and in vivo. Environ Toxicol 2017;32(8):1990-2003.
|
[[6]] |
Zhou P, Xie W, Meng X, et al. Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells 2019;8(3):213.
|
[[7]] |
Jian W, Yu S, Tang M, et al. A combination of the main constituents of Fufang Xueshuantong capsules shows protective effects against streptozotocin-induced retinal lesions in rats. J Ethnopharmacol 2016;182:50-56.
|
[[8]] |
Li C, Xu T, Zhou P, et al. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection. BMC Compl Alternat 2018;18(1):277.
|
[[9]] |
Xu C, Wang W, Wang B, et al. Analytical methods and biological activities of Panax notoginseng saponins: recent trends. J Ethnopharmacol 2019;236:443-465.
|
[[10]] |
Gu CZ, Lyu JJ, Zhang XX, et al. Triterpenoids with promoting effects on the differentiation of PC12 cells from the steamed roots of Panax notoginseng. J Nat Prod 2015;78(8):1829-1840.
|
[[11]] |
Liu MH, Yang BR, Cheung WF, et al. Transcriptome analysis of leaves, roots and flowers of Panax notoginseng identifies genes involved in ginsenoside and alkaloid biosynthesis. BMC Genomics 2015;16(1):265.
|
[[12]] |
Han S, Chen Y, Wang J, et al. Anti-thrombosis effects and mechanisms by Xueshuantongcapsule under different flow conditions. Front Pharmacol 2019;10:35.
|
[[13]] |
Wang FJ, Wang SX, Chai LJ, et al. Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress. Acta Pharmacol Sin 2018;39(6):998-1011.
|
[[14]] |
Huang Y, Guo B, Shi B, et al. Chinese herbal medicine Xueshuantong enhances cerebral blood flow and improves neural functions in Alzheimer's disease mice. J Alzheimer's Dis 2018;63(3):1089-1107.
|
[[15]] |
Liu Z, Zhang Q, Ding L, et al. Preparation procedure and pharmacokinetic study of water-in-oil nanoemulsion of Panax notoginseng saponins for improving the oral bioavailability. Curr Drug Deliv 2016;13(4):600-610.
|
[[16]] |
Chen XN, Li DQ, Zhao MD, et al. Pharmacokinetics of Panax notoginseng, saponins in adhesive and normal preparation of Fufang Danshen. Eur J Drug Metab Pharmacokinet 2018;43(2):215-225.
|
[[17]] |
Wu Y, Liu Y, Li X, et al. Research progress in in situ gelling ophthalmic drug delivery system. Asian J Pharm Sci 2019;14(1):1-15.
|
[[18]] |
Loftsson T, Stefánsson E. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye. Int J Pharmaceut 2017;531(2):413-423.
|
[[19]] |
Kaarniranta K, Xu H, Kauppinen A. Mechanistical retinal drug targets and challenge. Adv Drug Deliver Rev 2018;126:177-184.
|
[[20]] |
Wong CW, Wong TT. Posterior segment drug delivery for the treatment of exudative age-related macular degeneration and diabetic macular oedema. Br J Ophthalmol 2019;103(10):1356-1360.
|
[[21]] |
Gough G, Szapacs M, Shah T, et al. Ocular distribution and pharmacokinetic study of a small 13 kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits. Exp Eye Res 2018;167:14-17.
|
[[22]] |
Makwana SB, Patel VA, Parmar SJ. Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci 2015;6:1-6.
|
[[23]] |
Gote V, Sikder S, Sicotte J, et al. Ocular drug delivery: present innovations and future challenges. J Pharmacol Exp Ther 2019;370(3):602-624.
|
[[24]] |
Ye T, Yuan K, Zhang W, et al. Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery. Asian J Pharm Sci 2013;8(4):207-217.
|
[[25]] |
Shi H, Wang Y, Bao Z, et al. Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability. Int J Pharmaceut 2019;570:118688.
|
[[26]] |
Khattab A, Marzok S, Ibrahim M. Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of latanoprost: antiglaucoma efficacy and stability approaches. J Drug Deliv Sci Tec 2019;53:101134.
|
[[27]] |
Pang X, Li J, Pi J, et al. Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits. Pharm Dev Technol 2018;23(3):231-239.
|
[[28]] |
Zhang J, Xie Y, Zhou T, et al. Development of natamycin-hydroxypropyl-beta-cyclodextrin inclusion complex, ion-triggered in situ gel for sustained ocular delivery: in vitro, ex vivo evaluation and ocular pharmacokinetics study. Invest Ophth Vis Sci 2018;59(9):2676.
|
[[29]] |
Fernández-Ferreiro A, Silva-Rodríguez J, Otero-Espinar FJ, et al. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan. Eur J Pharm Biopharm 2017;114:317-323.
|
[[30]] |
Duan Y, Cai X, Du H, et al. Novelin situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin. Colloids Surf B Biointerfaces 2015;128:322-330.
|
[[31]] |
Wang H, Qin Y, Li B, et al. Biological modification of montan resin from lignite by Bacillus benzoevorans. Appl Biochem Biotechnol 2019;188(4):965-976.
|
[[32]] |
Ranch KM, Maulvi FA, Naik MJ, et al. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: in vitro, ex vivo, in vivo and human studies. Int J Pharm 2019;554:264-275.
|
[[33]] |
Wu H, Liu Z, Peng J, et al. Baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm 2011;410(1-2):31-40.
|
[[34]] |
Öztürk AA, Namli İ, Güleç K, et al. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: formulation, characterization and in vivo HET-CAM analysis. Microvasc Res 2020;130:103991.
|
[[35]] |
Ma Q, Luo R, Zhang H, et al. Design, characterization, and application of a pH-triggered in situ gel for ocular delivery of vinpocetine. AAPS Pharm Sci Tech 2020;21(7):253.
|
[[36]] |
Jain P, Jaiswal CP, Mirza MA, et al. Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations. Drug Dev Ind Pharm 2020;46(1):50-56.
|
[[37]] |
Bin-Jumah M, Gilani SJ, Jahangir MA, et al. Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular Irritation, and antimicrobial activity. Int J Nanomedicine 2020;15:7861-7875.
|
[[38]] |
Wang S, Li D, Pi J, et al. Pharmacokinetic and ocular microdialysis study of oral ginkgo biloba extract in rabbits by UPLC-MS/MS determination. J Pharm Pharmacol 2017;69(11):1540-1551.
|
[[39]] |
Jimenez J, Sakthivel M, Nischal KK, et al. Drug delivery systems and novel formulations to improve treatment of rare corneal disease. Drug Discov Today 2019;24(8):1564-1574.
|
[[40]] |
Chen J, Zhou R, Li L, et al. Mechanical, rheological and release behaviors of a poloxamer 407/poloxamer 188/carbopol 940 thermosensitive composite hydrogel. Molecules 2013;18(10):12415-12425.
|
[[41]] |
Adibkia K, Selselehjonban S, Emami S, et al. Electrosprayed polymeric nanobeads and nanofibers of modafinil: preparation, characterization, and drug release studies. Bioimpacts 2019;9(3):179-188.
|
[[42]] |
Allam A, El-Mokhtar MA, Elsabahy M. Vancomycin-loaded niosomes integrated within pH-sensitive in situ forming gel for treatment of ocular infections while minimizing drug irritation. J Pharm Pharmacol 2019;71(8):1209-1221.
|
[[43]] |
Liu S, Cui M, Liu Z, et al. Structural analysis of saponins from medicinal herbs using electrospray ionization tandem mass spectrometry. J Am Soc Mass Spectrom 2004;15(2):133-141.
|
[[44]] |
Huhman DV, Sumner LW. Metabolic profiling of saponins in Medicago sativa and Medicago truncatula using HPLC coupled to an electrospray ion-trap mass spectrometer. Phytochemistry 2002;59(3):347-360.
|
[[45]] |
Daull P, Raymond E, Feraille L, et al. Safety and tolerability of overdosed artificial tears by abraded rabbit corneas. J Ocul Pharmacol Ther 2018;34(10):670-676.
|
/
〈 | 〉 |